跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40,923 条关于
“MaxCyte, Inc.”
全部
40,923
临床试验
11,217
药物
1,608
机构
6,168
资讯
21,930
去年
MaxCyte Partners with Anocca to Advance TCR-T Cell Therapy Manufacturing Using Non-Viral Gene Editing Platform
上个月
MaxCyte Licenses Multi-Platform Cell Engineering Technology to Genentech for Cell Therapy Development
29天前
MaxCyte Launches CHANGE-seq-BE and ONE-seq-BE to Strengthen Off-Target Assessment for Base Editing Therapies
去年
MaxCyte and Ori Biotech Partner to Enhance CAR-T Cell Manufacturing Through Platform Integration
去年
FDA Approves Roche's Injectable Ocrevus, Novartis' Kisqali, and Lilly's Ebglyss; WHO Clears Bavarian Nordic’s Mpox Vaccine
去年
TG Therapeutics Partners with MaxCyte to Advance Novel CAR T-Cell Therapy for Progressive MS
去年
Virios Therapeutics and Wex Pharmaceuticals Merge to Form Dogwood Therapeutics, Advancing Novel Pain and Viral Therapies
去年
LYMPHIR and Pembrolizumab Combination Shows Promise in Recurrent Solid Tumors
去年
Alnylam Pharmaceuticals Inc (ALNY) Q3 2024 Earnings Highlights
去年
IDEAYA Biosciences, Inc. (IDYA) BCG Matrix Analysis 2024
第 1 页,共 2193 页
上一页
下一页